{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Erythropoietin (EPO) assay",
        "ADVIA Centaur\u00ae Erythropoietin (EPO) Assay"
    ],
    "Submitter Information": "Axis-Shield Diagnostics Limited",
    "510(k) Number": "K183088",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052223"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGT"
    ],
    "Summary Letter Date": "August 2, 2019",
    "Summary Letter Received Date": "July 3, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7250"
    ],
    "Regulation Name(s)": [
        "Erythropoietin Assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "immunology"
    ],
    "Analyte(s)": [
        "Erythropoietin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "Serum separator tube",
        "Plasma separator tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent kit",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Erythropoietin (EPO) assay measuring erythropoietin in serum or plasma using a chemiluminescent immunoassay on the ADVIA Centaur XP system",
    "Indications for Use Summary": "Quantitative measurement of erythropoietin in pediatric and adult human serum or plasma as an aid in the diagnosis of anemias and polycythemias",
    "fda_folder": "Hematology"
}